sBLA Submitted for Amivantamab/Lazertinib for Locally Advanced/Metastatic NSCLC

1 year ago 45

The application for amivantamab and lazertinib for locally advanced or metastatic non–small cell lung cancer is supported by data from the phase 3 MARIPOSA-2 trial.

1. Homepage
2. Lung Cancer
3. sBLA Submitted for Amivantamab/Lazertinib for Locally Advanced/Metastatic NSCLC